U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H22ClN.2H3O4P
Molecular Weight 507.839
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of PYRROBUTAMINE PHOSPHATE

SMILES

OP(O)(O)=O.OP(O)(O)=O.ClC1=CC=C(CC(=CCN2CCCC2)C3=CC=CC=C3)C=C1

InChI

InChIKey=UAAAHOLLLRWGGL-UHFFFAOYSA-N
InChI=1S/C20H22ClN.2H3O4P/c21-20-10-8-17(9-11-20)16-19(18-6-2-1-3-7-18)12-15-22-13-4-5-14-22;2*1-5(2,3)4/h1-3,6-12H,4-5,13-16H2;2*(H3,1,2,3,4)

HIDE SMILES / InChI

Description

PYRROBUTAMINE is a potent H1-antihistamine. H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate the inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria.

Approval Year

1952
115
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Approved
8429
Pyronil

Approved Use

Antihistaminic
Sourcing

Sourcing

Vendor/AggregatorIDURL
Alfa Chemistry
ACM28296642
Compound Cloud
5284614
Norris Pharm
NSZB-A030895
Toronto Research Chemicals
P997800
ZINC
ZINC000004474657
http://zinc15.docking.org/substances/ZINC000004474657
ZINC
ZINC000015848271
http://zinc15.docking.org/substances/ZINC000015848271
eMolecules
45955538
PubMed

PubMed

TitleDatePubMed
Antihistaminic action of pyronil.
1952 Jul
Chemical and pharmacological characteristics of the antihistaminic compound, pyrrobutamine.
1953 Nov-Dec
Name Type Language
PYRROBUTAMINE PHOSPHATE
WHO-DD  
Common Name English
PYRROBUTAMINE DIPHOSPHATE [MI]
Common Name English
Pyrrobutamine phosphate [WHO-DD]
Common Name English
PYRROBUTAMINE DIPHOSPHATE
MI  
Common Name English
PYRROLIDINE, 1-(4-(4-CHLOROPHENYL)-3-PHENYL-2-BUTENYL)-, PHOSPHATE (1:2)
Systematic Name English
1-(.GAMMA.-(P-CHLOROBENZYL)CINNAMYL)PYRROLIDINE PHOSPHATE (1:2)
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29578
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
Code System Code Type Description
EVMPD
SUB15067MIG
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
MERCK INDEX
m9396
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY Merck Index
CAS
135-31-9
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
EPA CompTox
DTXSID90859160
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
PUBCHEM
8668
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
SMS_ID
100000078916
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
FDA UNII
6B6107K1Q6
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
ChEMBL
CHEMBL1697849
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
NCI_THESAURUS
C81136
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
ECHA (EC/EINECS)
205-185-3
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of PYRROBUTAMINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966